Tag Archives: NASDAQ:ZGNX
Zogenix (NASDAQ:ZGNX) Post Smaller Loss in Fiscal Q4; Ends Marketing Partnership – ZGNX, AGN, ENDP, ALKS
The SAN DIEGO, California based Zogenix, Inc (NASDAQ:ZGNX) announced on Friday that it had a smaller loss in fiscal Q4 after it finished a marketing partnership on its injectable migraine treatment, Sumavel DosePro.
Zogenix ended a marketing partnership with Japanese …
MAP Pharmaceuticals (NASDAQ:MAPP) Wins FDA Approval for Levadex; Stock Hikes – MAPP, AGN, PATH, ZGNX
The Mountain View, California based MAP Pharmaceuticals Inc’s (NASDAQ:MAPP) stock hiked on Friday after encouraging regulatory news on what could become the corporation’s primary approved product.
MAP reported that the United States Food and Drug Administration permitted the drug developer’s …